de Klein A - Search Results

1

Association between RB-1 gene alterations and factors of favourable prognosis in human breast cancer, without effect on survival.

Berns EM, de Klein A, van Putten WL, van Staveren IL, Bootsma A, Klijn JG, Foekens JA. Berns EM, et al. Among authors: de klein a. Int J Cancer. 1995 Apr 21;64(2):140-5. doi: 10.1002/ijc.2910640212. Int J Cancer. 1995. PMID: 7615356

2

[Oncogenes, tumor suppression genes and medical genetics of cancer].

Bootsma AH, Cornelisse CJ, de Klein A. Bootsma AH, et al. Among authors: de klein a. Ned Tijdschr Geneeskd. 1992 May 23;136(21):1009-13. Ned Tijdschr Geneeskd. 1992. PMID: 1318508 Review. Dutch. No abstract available.

3

Genetic changes in somatostatin receptor positive breast tumors.

Bootsma AH, de Klein A, Reubi JC, Zwarthoff EC, Lamberts SW. Bootsma AH, et al. Among authors: de klein a. J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):829-32. doi: 10.1016/0960-0760(90)90427-m. J Steroid Biochem Mol Biol. 1990. PMID: 1981016

4

Linkage to markers for the chromosome region 17q12-q21 in 13 Dutch breast cancer kindreds.

Devilee P, Cornelis RS, Bootsma A, Bardoel A, van Vliet M, van Leeuwen I, Cleton FJ, de Klein A, Lindhout D, Vasen HF, et al. Devilee P, et al. Among authors: de klein a. Am J Hum Genet. 1993 Apr;52(4):730-5. Am J Hum Genet. 1993. PMID: 8096358 Free PMC article.

5

Somatostatin receptor-positive primary breast tumors: genetic, patient and tumor characteristics.

Bootsma AH, van Eijck C, Schouten KK, Reubi JC, Waser B, Foekens JA, van Pel R, Zwarthoff EC, Lamberts SW, de Klein A. Bootsma AH, et al. Among authors: de klein a. Int J Cancer. 1993 May 28;54(3):357-62. doi: 10.1002/ijc.2910540302. Int J Cancer. 1993. PMID: 8099570

6

Breakpoint heterogeneity in t(10;11) translocation in AML-M4/M5 resulting in fusion of AF10 and MLL is resolved by fluorescent in situ hybridization analysis.

Beverloo HB, Le Coniat M, Wijsman J, Lillington DM, Bernard O, de Klein A, van Wering E, Welborn J, Young BD, Hagemeijer A, et al. Beverloo HB, et al. Among authors: de klein a. Cancer Res. 1995 Oct 1;55(19):4220-4. Cancer Res. 1995. PMID: 7671224

7

Detection of genetic prognostic markers in uveal melanoma biopsies using fluorescence in situ hybridization.

Naus NC, Verhoeven AC, van Drunen E, Slater R, Mooy CM, Paridaens DA, Luyten GP, de Klein A. Naus NC, et al. Among authors: de klein a. Clin Cancer Res. 2002 Feb;8(2):534-9. Clin Cancer Res. 2002. PMID: 11839674

8

Concurrent loss of chromosome arm 1p and chromosome 3 predicts a decreased disease-free survival in uveal melanoma patients.

Kilic E, Naus NC, van Gils W, Klaver CC, van Til ME, Verbiest MM, Stijnen T, Mooy CM, Paridaens D, Beverloo HB, Luyten GP, de Klein A. Kilic E, et al. Among authors: de klein a. Invest Ophthalmol Vis Sci. 2005 Jul;46(7):2253-7. doi: 10.1167/iovs.04-1460. Invest Ophthalmol Vis Sci. 2005. PMID: 15980208

9

Molecular cytogenetic analysis of archival uveal melanoma with known clinical outcome.

Mensink HW, Kiliç E, Vaarwater J, Douben H, Paridaens D, de Klein A. Mensink HW, et al. Among authors: de klein a. Cancer Genet Cytogenet. 2008 Mar;181(2):108-11. doi: 10.1016/j.cancergencyto.2007.12.001. Cancer Genet Cytogenet. 2008. PMID: 18295662

10

Higher percentage of FISH-determined monosomy 3 and 8q amplification in uveal melanoma cells relate to poor patient prognosis.

van den Bosch T, van Beek JG, Vaarwater J, Verdijk RM, Naus NC, Paridaens D, de Klein A, Kiliç E. van den Bosch T, et al. Among authors: de klein a. Invest Ophthalmol Vis Sci. 2012 May 14;53(6):2668-74. doi: 10.1167/iovs.11-8697. Invest Ophthalmol Vis Sci. 2012. PMID: 22427574

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

246 results

Search Page

Filters